Webcast Link: To Be Provided on the IR portion of Beam Global’s Website This Beam Global Press Release may contain forward-looking statements. All statements in this Press Release other than ...
Investor's Business Daily on MSN
Beam Therapeutics shows rising relative strength; still shy of key benchmark
Beam Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...
CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (BEAM) (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced ...
The live webcasts will be available in the investor section of the company's website at www.beamtx.com and will be archived for 60 days following the presentation. About Beam TherapeuticsBeam ...
This Beam Global Press Release may contain forward-looking statements. All statements in this Press Release other than statements of historical facts are forward-looking statements. Forward-looking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results